{
    "paper_id": "PMC7136890",
    "metadata": {
        "title": "Conducting phase 1 cancer clinical trials during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)\u2013related disease pandemic",
        "authors": [
            {
                "first": "Paolo",
                "middle": [],
                "last": "Tarantino",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Dario",
                "middle": [],
                "last": "Trapani",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Giuseppe",
                "middle": [],
                "last": "Curigliano",
                "suffix": "",
                "email": "Giuseppe.curigliano@ieo.it",
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "No funding support was received for this work.",
            "cite_spans": [],
            "section": "Funding",
            "ref_spans": []
        },
        {
            "text": "P.T. and D.T. declare no potential conflicts of interest related to this work.",
            "cite_spans": [],
            "section": "Conflict of interest statement",
            "ref_spans": []
        },
        {
            "text": "G.C. reports receiving honoraria for a speaker and consultancy or advisory rule from Roche, Pfizer, Novartis, Seattle Genetics, Lilly, Ellipses Pharma, Foundation Medicine and Samsung.",
            "cite_spans": [],
            "section": "Conflict of interest statement",
            "ref_spans": []
        }
    ],
    "ref_entries": {},
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "COVID-19 and Italy: what next?",
            "authors": [
                {
                    "first": "A.",
                    "middle": [],
                    "last": "Remuzzi",
                    "suffix": ""
                },
                {
                    "first": "G.",
                    "middle": [],
                    "last": "Remuzzi",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/S0140-6736(20)30627-9"
                ]
            }
        },
        "BIBREF1": {
            "title": "Risk of COVID-19 for patients with cancer",
            "authors": [
                {
                    "first": "H.",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "L.",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet Oncol",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/S1470-2045(20)30149-2"
                ]
            }
        },
        "BIBREF2": {
            "title": "Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy",
            "authors": [
                {
                    "first": "G.",
                    "middle": [],
                    "last": "Onder",
                    "suffix": ""
                },
                {
                    "first": "G.",
                    "middle": [],
                    "last": "Rezza",
                    "suffix": ""
                },
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Brusaferro",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Am Med Assoc",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1001/jama.2020.4683"
                ]
            }
        },
        "BIBREF3": {
            "title": "Phase I trials as valid therapeutic options for patients with cancer",
            "authors": [
                {
                    "first": "J.J.",
                    "middle": [],
                    "last": "Adashek",
                    "suffix": ""
                },
                {
                    "first": "P.M.",
                    "middle": [],
                    "last": "LoRusso",
                    "suffix": ""
                },
                {
                    "first": "D.S.",
                    "middle": [],
                    "last": "Hong",
                    "suffix": ""
                },
                {
                    "first": "R.",
                    "middle": [],
                    "last": "Kurzrock",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Nat Rev Clin Oncol",
            "volume": "16",
            "issn": "",
            "pages": "773-778",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF4": {
            "title": "FDA guidance on conduct of clinical trials of medical products during COVID-19 pandemic",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF5": {
            "title": "COVID-19 control in China during mass population movements at new year",
            "authors": [
                {
                    "first": "S.",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "J.",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "W.",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "C.",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "T.",
                    "middle": [],
                    "last": "B\u00e4rnighausen",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet",
            "volume": "395",
            "issn": "",
            "pages": "764-766",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF6": {
            "title": "Virtually perfect? Telemedicine for covid-19",
            "authors": [
                {
                    "first": "J.E.",
                    "middle": [],
                    "last": "Hollander",
                    "suffix": ""
                },
                {
                    "first": "B.G.",
                    "middle": [],
                    "last": "Carr",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1056/NEJMp2003539"
                ]
            }
        }
    }
}